Literature DB >> 24323367

Regulation of cancer metabolism by O-GlcNAcylation.

Zhonghua Li1, Wen Yi.   

Abstract

Cancer cells exhibit increased uptake of glucose and glutamine, and rewire the metabolic flux toward anabolic pathways important for cell growth and proliferation. Understanding how this altered metabolism is regulated has recently emerged as an intense research focus in cancer biology. O-linked β-N-acetylglucosamine (O-GlcNAc) is a reversible posttranslational modification of serine and/or threonine residues of nuclear and cytosolic proteins. O-GlcNAcylation has been identified in numerous proteins that are involved in many important cellular functions, including transcription, translation, signal transduction, and stress responses. More recently, increasing evidence indicates that O-GlcNAcylation plays important roles in regulating cancer metabolic reprogramming by modifying key transcription factors, metabolic enzymes and major oncogenic signaling pathways. Thus, O-GlcNAcylation emerges as a novel regulatory mechanism linking altered metabolism to cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323367     DOI: 10.1007/s10719-013-9515-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  71 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions.

Authors:  Won Ho Yang; Sang Yoon Park; Hyung Wook Nam; Do Hyun Kim; Jeong Gu Kang; Eun Seok Kang; Yu Sam Kim; Hyun Chul Lee; Kwan Soo Kim; Jin Won Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

4.  O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.

Authors:  Wenyi Mi; Yuchao Gu; Cuifang Han; Haiyan Liu; Qiong Fan; Xinling Zhang; Qi Cong; Wengong Yu
Journal:  Biochim Biophys Acta       Date:  2011-01-19

5.  Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.

Authors:  S A Caldwell; S R Jackson; K S Shahriari; T P Lynch; G Sethi; S Walker; K Vosseller; M J Reginato
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

6.  Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils.

Authors:  Zachary T Kneass; Richard B Marchase
Journal:  J Biol Chem       Date:  2005-02-09       Impact factor: 5.157

Review 7.  Using natural product inhibitors to validate Hsp90 as a molecular target in cancer.

Authors:  Len Neckers
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

8.  c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas.

Authors:  T Y Chou; G W Hart; C V Dang
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

9.  Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains.

Authors:  Yobana Perez-Cervera; Vanessa Dehennaut; Moyira Aquino Gil; Katia Guedri; Carlos Josué Solórzano Mata; Stéphanie Olivier-Van Stichelen; Jean-Claude Michalski; François Foulquier; Tony Lefebvre
Journal:  FASEB J       Date:  2013-05-20       Impact factor: 5.191

Review 10.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

View more
  9 in total

Review 1.  Proteomic approaches for site-specific O-GlcNAcylation analysis.

Authors:  Sheng Wang; Feng Yang; David G Camp; Karin Rodland; Wei-Jun Qian; Tao Liu; Richard D Smith
Journal:  Bioanalysis       Date:  2014       Impact factor: 2.681

2.  O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.

Authors:  Xiongjian Rao; Xiaotao Duan; Weimin Mao; Xuexia Li; Zhonghua Li; Qian Li; Zhiguo Zheng; Haimiao Xu; Min Chen; Peng G Wang; Yingjie Wang; Binghui Shen; Wen Yi
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

3.  Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.

Authors:  Katarzyna Starska; Ewa Forma; Ewa Brzezińska-Błaszczyk; Iwona Lewy-Trenda; Magdalena Bryś; Paweł Jóźwiak; Anna Krześlak
Journal:  Clin Exp Med       Date:  2014-10-15       Impact factor: 3.984

Review 4.  Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.

Authors:  Parunya Chaiyawat; Pukkavadee Netsirisawan; Jisnuson Svasti; Voraratt Champattanachai
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-11       Impact factor: 5.555

5.  Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.

Authors:  Masayoshi Munemoto; Ken-Ichi Mukaisho; Tomoharu Miyashita; Katsunobu Oyama; Yusuke Haba; Koichi Okamoto; Jun Kinoshita; Itasu Ninomiya; Sachio Fushida; Naoko Taniura; Hiroyuki Sugihara; Takashi Fujimura
Journal:  Cancer Sci       Date:  2019-07-23       Impact factor: 6.716

Review 6.  The potential role of O-GlcNAc modification in cancer epigenetics.

Authors:  Ewa Forma; Paweł Jóźwiak; Magdalena Bryś; Anna Krześlak
Journal:  Cell Mol Biol Lett       Date:  2014-08-20       Impact factor: 5.787

Review 7.  Chemistry-Assisted Proteomic Profiling of O-GlcNAcylation.

Authors:  Qiang Zhu; Wen Yi
Journal:  Front Chem       Date:  2021-06-25       Impact factor: 5.221

8.  O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.

Authors:  Minjun Kim; Yoon Sook Kim; Hwajin Kim; Min Young Kang; Jeongsook Park; Dong Hoon Lee; Gu Seob Roh; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Ji Kwon Park; Jin Won Cho; Jeong Kyu Shin; Wan Sung Choi
Journal:  Oncotarget       Date:  2016-07-12

9.  Thio-Linked UDP-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.

Authors:  Karim Rafie; Andrii Gorelik; Riccardo Trapannone; Vladimir S Borodkin; Daan M F van Aalten
Journal:  Bioconjug Chem       Date:  2018-05-10       Impact factor: 4.774

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.